
Yahoo · 29 de jul de 2026
Cardinal Health stock has delivered a very strong 334.8% return over the past five years, yet its current checks lean expensive and suggest the recent share pri…
Cardinal Health Inc
Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile and non-sterile procedure kits. Additionally, it manufactures, prepares, and delivers radiopharmaceuticals; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.
Últimos 168 días · 12/11/25 — 24/07/26
+21.19%
Precio de cierre en pesos argentinos. Fuente: data912.
Precio
$ 123.750
Var. %
0%
Precio CAH
US$ 232,41
Teórico (precio / ratio)
CAH ÷ 3
US$ 77,47
Cotización
US$ 79,10
vs teórico
+2,1%
Cotización MEP implícita
$ 1.564,48
Cotización
—
vs teórico
—
Cotización Cable implícita
—
Sí, existe el CEDEAR de CAH (Cardinal Health Inc) en la Bolsa de Comercio de Buenos Aires (BYMA). Su ticker local es CAH.
El ticker del CEDEAR de Cardinal Health Inc en Argentina es CAH. La acción subyacente cotiza en NYSE con el símbolo CAH.
El CEDEAR CAH tiene un ratio de 3:1. Eso significa que 3 CEDEARs equivalen a 1 acción de CAH.
El CEDEAR CAH cotiza hoy a $ 123.750 en pesos argentinos, con una variación diaria de 0%.
La acción subyacente CAH (Cardinal Health Inc) cotiza a US$ 232,41 en su mercado de origen (NYSE).
El precio teórico del CEDEAR CAH se calcula dividiendo el precio de CAH por el ratio (3). Hoy resulta en US$ 77,47.
En BYMA podés operar CAH en pesos, CAHD en dólar MEP y CAHC en dólar cable. Cada modalidad refleja un tipo de cambio distinto.
En esta página encontrás un gráfico con el precio histórico del CEDEAR CAH en pesos argentinos, con datos de data912.

Yahoo · 29 de jul de 2026
Cardinal Health stock has delivered a very strong 334.8% return over the past five years, yet its current checks lean expensive and suggest the recent share pri…

Yahoo · 29 de jul de 2026
Battery Ventures is co-leading the round alongside NewRoad Capital Partners, with participation from PSP Growth, Nexus Venture Partners and othersFreehand's AI…

Yahoo · 29 de jul de 2026
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Those leading the charge have not only realized…

Yahoo · 28 de jul de 2026
In the most recent trading session, Cardinal Health (CAH) closed at $232.51, indicating a +1.38% shift from the previous trading day.

Yahoo · 28 de jul de 2026
ECL stock rises pre-market after earnings and revenues beat estimates, as pricing, volume growth and core-business demand lift organic sales.

Yahoo · 28 de jul de 2026
OPK beats Q2 estimates as pharmaceutical growth, Nicoya income and lower costs narrow losses and lift shares pre-market.

Yahoo · 28 de jul de 2026
CVS, CAH, HUM and ACAD show favorable earnings indicators ahead of Q2 results as healthcare demand stays resilient despite margin pressures.

Yahoo · 27 de jul de 2026
CI's Q2 earnings are likely to face pressure from fewer insured medical customers and a higher MCR despite expected revenue growth.
Noticias vía Finnhub